(Q52885667)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Alexandar Tzankov

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Margot Thome

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

S-S Wenzel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

C Mavis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

S Hailfinger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

A Wolf

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

H Madle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

G Deeb

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

B Dörken

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

P Lenz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

S Dirnhofer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

F J Hernandez-Ilizaliturri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

G Lenz

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

21 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

1381-1390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2012.367

21 February 2020

exact match

0 references

cites work

Pathogenesis of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Stromal gene signatures in large-B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

The BCL-2 protein family: opposing activities that mediate cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Myeloid cell leukemia-1 as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Mcl-1; the molecular regulation of protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Simultaneous targeting of MCL1 and ABCB1 as a novel strategy to overcome drug resistance in human leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

A loss-of-function RNA interference screen for molecular targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

MCL-1 expression in B-cell non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

The landscape of somatic copy-number alteration across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

inferred from DOI database lookup

7 January 2021

based on heuristic

Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.367

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2012.367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23257783%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference